Seminars in Arthritis and Rheumatism

Article	Citations
Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals’ Public Assistance	94
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis	86
Hydroxyquinone use does not increase the risk of venous thromboembolism in rheumatoid arthritis patients—Real-world evidence from a population-based cohort study	80
Response letter to the editor	59
Letter to the editor regarding Outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: A meta-analysis and systematic review	50
OMERACT validation of a deep learning algorithm for automated absolute quantification of knee joint effusion versus manual semi-quantitative assessment	50
Looking at Fibromyalgia differently – the meaning and consequences of fibromyalgia as a dimensional disorder	50
mRNA vaccines in the rheumatologist's future	45
Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes	43
Response to the correspondence by Xu et al. regarding "Toward a more actionable RA-ILD risk model"	41
Is mixed connective tissue disease (MCTD) a subtype of systemic sclerosis?	40
Metabolomics in systemic lupus erythematosus: A systematic review and meta-analysis	40
Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial	40
Corrigendum to “Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice” [Seminars in Arthritis and Rheumatism 71 (2025) 152640]	39
Immunotherapy in cancer	38
Interstitial lung disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis: chest CT patterns and correlation with survival	38
Risk prediction models for incident systemic lupus erythematosus among women in the Nurses’ health study cohorts using genetics, family history, and lifestyle and environmental factors	37
Quantification of coronary artery calcification in systemic sclerosis using visual ordinal and deep learning scoring: Association with systemic sclerosis clinical features	36
Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort	35
Exploring the association between adiposity, pain intensity, and effusion-synovitis in people with knee osteoarthritis: A cross-sectional study	34
Correspondence to ‘Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors’	34
Update on IgG4-related periaortitis/retroperitoneal fibrosis and periarteritis -recent clinical, diagnostic and therapeutic advances	33
Almost half of the patients with axial spondyloarthritis reporting an acceptable symptom state have high disease activity; data from two standard-of-care cohorts	33
Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis	32
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments	31

HIF-1α in Gout: A central regulator of metabolism, inflammation, and environmental stress	31
The Autoantibody response in rheumatoid arthritis; what makes it unique?	31
Systemic sclerosis-related digital ulcers: Current understanding and updated management approaches- a primer for clinicians	30
Evaluation of disease severity and treatment responses in patients with enthesitis-related arthritis	30
Refining RA-ILD screening: Diagnostic limitations and the emerging role of lung ultrasound	29
A clue for subclinical CNO in adolescents with acne conglobata and hidradenitis suppurativa: Persistan acute phase rectans elevation	29
The clinical features of juvenile dermatomyositis: A single-centre inception cohort	29
Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis?	29
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial	27
Prevalence of crystal deposits in asymptomatic hyperuricemia according to different scanning definitions: A comparative study	27
The state of the Osteoarthritis Initiative (OAI): Entering a new era	27
Using patient reported outcomes measurement information system (PROMIS®) measures in rheumatoid arthritis clinical care, research, and trials	27
A population-based analysis of rheumatology care patterns for inflammatory arthritis during COVID-19 in Alberta, Canada	26
Raynaud's phenomenon secondary to central nervous system stimulants: A therapeutic role of α-1 adrenergic blockers?	26
Interstitial lung disease phenotype in mixed, differentiated, or overlapping, connective tissue diseases: Comment on the article by Boleto et al.	26
Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis	26
Response to: Comment to “Vitamin D in psoriatic arthritis—A systematic review and meta-analysis”	25
Correspondence on “Central sensitization has major impact on quality of life in patients with axial spondyloarthritis” By Kieskamp et al.	25
Outcomes of respiratory syncytial virus infection in patients with systemic autoimmune rheumatic disease	25
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritis	25
Is there room for precocious prevention in rheumatoid arthritis precision medicine? A temporal and stratified reframing in diagnostic and therapeutic pathway	25
Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registry	24
A cohort study on the associations between age at natural menopause and rheumatoid arthritis in postmenopausal women from the Canadian Longitudinal Study on Aging	24
Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis – A cohort study	24
Psychological stress in rheumatoid arthritis: a systematic scoping review	24
A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis	24
Corrigendum to “The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time” [Seminars in Arthritis and Rheumatism 55 (2022):152010]	24
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis	24
Giant cell arteritis associated with scalp, tongue or lip necrosis: A French multicenter case control study	23
Response to Chen and Liu regarding correspondence to “Development of a prediction model for progression of rheumatoid arthritis–associated interstitial lung disease using serologic and clinical factor	23
Sodium-glucose cotransporter 2 (SGLT2) inhibition and autoimmunity	23
Targeting the Wnt pathway for the treatment of Osteoarthritis of the knee	22
Hematopoietic stem cell transplant, chimeric antigen receptor T-cells, and other cellular therapies as stepping stones toward long-term improvement in severe scleroderma and other autoimmune diseases	22
Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial	22
AA amyloidosis in inflammatory joint diseases: A systematic review	22
Effect of zoledronic acid with or without methylprednisolone on 3D bone area and bone shape in patients with symptomatic knee osteoarthritis: A post-hoc analysis of the ZAP2 trial	22
Longitudinal changes on cranial magnetic resonance imaging in relapsing giant cell arteritis	22
Response to commentary on IgG4-related uveitis. A French cohort and literature review	22
Sarcoidosis incidence after mTOR inhibitor treatment	21
Response: Early referral of patients with suspected polymyalgia rheumatica: An active involvement of the out-of-hospital public rheumatologist is needed. Reply letter to Ciro Manzo (letter to the edit	21
Therapeutic approach to central nervous system involvement of Behçet's disease	20
Defining a personalized treatment approach to rheumatoid arthritis: Using genetic markers of TNFi response	20
Improvement of bone mineral density and new vertebral fractures during 8 years of TNF-α inhibition in patients with axial spondyloarthritis	20
Mechanisms of joint pain: Five short lessons from osteoarthritis	20
HRCT imaging of pulmonary involvement in granulomatosis with polyangiitis and microscopic polyangiitis at disease onset and during follow-up	20
Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis	19
Systematic review of colchicine neuromyopathy: Risk factors, duration and resolution	19
Pathogenesis and targets in uveitis	19
The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing	19
Causal association of diet-derived circulating antioxidants with the risk of rheumatoid arthritis: A Mendelian randomization study	19

The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review	19
Looking at fibromyalgia differently – An observational study of the meaning and consequences of fibromyalgia as a dimensional disorder	18
Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofaciti	18
Effects of exercise-based interventions on inflammatory markers in patients with fibromyalgia: A systematic review and meta-analysis	18
Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis	18
Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: A systematic review and meta-analysis	17
Is there a role for Pneumocystis jiroveci pneumonia prophylaxis in giant cell arteritis or polymyalgia rheumatica?	17
Response to letter to the editor regarding "Nailfold Capillaroscopy as a predictor of cardiovascular events and mortality in systemic sclerosis"	17
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients	17
Molecular mechanisms underlying thrombosis in systemic lupus erythematosus – A Systematic review	17
Autonomic dysfunction symptoms in Sjögren’s Disease: A missed dimension linked to disease burden and work disability	16
The role of sex and systemic inflammation in the development of cardiovascular disease in osteoarthritis: A population-based cohort study using the CLSA	16
Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of	16
Comment on: Miedany et al. Beyond the symptoms: Personalizing giant cell arteritis care through multidimensional patient reported outcome measure	16
Association between Kawasaki disease and subsequent autoimmune disease: National cohort study of adolescents with 12-year follow-up from birth	16
Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial	16
Discriminating capacity of the ASAS health index in patients with axial spondyloarthritis treated with ixekizumab	16
Advances in Targeted Therapies (ATT) What's cooking in the academic's kitchen? 3TR (IMI)	16
Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysis	16
CAR T-cell therapy in SLE: A systematic review	16
The control group matters: Pain, physical function and strength improvements relative to the comparator intervention in knee and hip osteoarthritis	16
Further expanding the clinical spectrum of giant cell arteritis: Non-classical organ involvement and uncommon complications	16
Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women	15
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosis	15
Biologics in peripheral ulcerative keratitis	15
Reply on: International, multidisciplinary Delphi consensus recommendations on non-pharmacological interventions for fibromyalgia	15
Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis	15
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group	15
Re: comment on: Miedany et al. response letter: Beyond the symptoms: personalizing giant cell arteritis care through multidimensional patient reported outcome measure. Volume 75, December 2025, 152844	15
Juvenile and adult-onset scleroderma: Different clinical phenotypes	15
Effects of neuromuscular control and strengthening exercises on MRI-measured thigh tissue composition and muscle properties in people with knee osteoarthritis – an exploratory secondary analysis from	15
Comparison between rheumatoid arthritis with malignant lymphoma and other malignancies: Analysis of a National Database of Rheumatic Disease in Japan	15
Co-occurrence of giant cell arteritis in patients with polymyalgia rheumatica. Comment on the article by Nielsen AW, et al	15
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world da	15
Predicting anxiety and depression in systemic lupus erythematosus: the role of inflammation, sociodemographic variables and clinical factors	15
Correspondence to 'Nailfold capillaroscopy as a predictor of major cardiovascular events and mortality in systemic sclerosis'	15
Synovial fibroblasts in juvenile idiopathic arthritis: A scoping review	15
Comments on the article by Goldman et al.	15
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis	15
Preventive effect of beta-blockers in the development of aortic dilation in giant cell arteritis-related aortitis	15
Autoinflammatory syndromes with coexisting variants in Mediterranean FeVer and other genes: Utility of multiple gene screening and the possible impact of gene dosage	15
An analysis of the first relapse in giant cell arteritis using ultrasonography	14
Response to: ‘Critical Commentary ‘Infectious complications of Belimumab with standard care in systemic lupus erythematosus: A systematic review and meta-analysis’ by Saketh Sainag Mandiga et al	14
Modelling long-term outcomes for patients with systemic lupus erythematosus	14
Epicardial fat as a cardiovascular risk factor in inflammatory arthritis	14
Methotrexate use reduces mortality risk in rheumatoid arthritis: A systematic review and meta-analysis of cohort studies	14
Psychometric properties of patient-reported outcomes measurement information system (PROMIS) fixed short forms in Juvenile Myositis	14
How is early spondyloarthritis defined in the literature? Results from a systematic review	14
Factors associated with cardiovascular events in systemic lupus erythematosus in a monocentric cohort with up to 40 years of follow-up	14
Definitions and online reliability assessment of elementary ultrasound lesions in Takayasu arteritis: a study from the OMERACT Ultrasound Working Group	14
Response to letter concerning article entitled "Central sensitization has major impact on quality of life in patients with axial spondyloarthritis	14
Self-esteem, self-concept, and body image of young people with rheumatic and musculoskeletal diseases: A systematic literature review	14
Autoimmune rheumatic disease in Australian Aboriginal and Torres Strait Islander Peoples: What do we know?	14
Acknowledgement of Referees	14
Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets	14
Paraproteinemias in Sjögren disease: cryoglobulinemia and serum monoclonal gammopathy identify distinct clinical phenotypes and differential lymphoma susceptibility	14
Response to the letter entitled " Letter to the editor to Soluble CXCL16 is a prognostic biomarker associated with rapidly progressive interstitial lung disease complicated with dermatomyositis" by Ga	14
Erratum to “Magnetic resonance imaging for adult idiopathic inflammatory myopathies: a scoping review of protocols, grading systems and applications”[Seminars in Arthritis and Rheumatism Volume 75, (2	14
Subclinical coronary artery calcification in systemic sclerosis using high-resolution chest CT: Identification, extent, and disease-specific risk factors	14
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group	13
Unraveling the role of neutrophil extracellular traps in rheumatoid arthritis: From triggers to therapeutic targets	13
The natural history of end-stage knee osteoarthritis: Data from the osteoarthritis initiative	13
Minimally invasive interventional procedures for osteoarthritis and inflammatory arthritis: A systematic review and meta-analysis	13
Giant cell arteritis-related stroke in a large inception cohort: A comparative study	13
Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis	13
Predicting best treatment in rheumatoid arthritis	13
Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus	13
Rheumatoid arthritis and the risk of 90-day readmission after hospitalization for heart failure	13
Remission in gout is possible: 5-year follow-up in the NOR-Gout study	13
Does the time to the onset of lupus nephritis impact renal disease presentation and outcomes?	13
Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice	13
The prognostic power of anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis - A systematic review of the literature	12
Hospitalization risk in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis: A matched cohort study	12
Risk of new onset of immune-mediated diseases after SARS-CoV-2 infection: A systematic review and meta-analysis	12
Algorithmic approaches in hand imaging for rheumatic musculoskeletal diseases: A systematic literature review	12
Critical commentary: Factors associated with thrombosis in Behçet syndrome: A systematic review and meta-analysis	12
Does body mass index mediate the relationship between socioeconomic position and incident osteoarthritis?	12
Impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis	12
Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options	12
Aortic disease in giant cell arteritis	12

Hormone therapy in menopause increases rheumatoid arthritis risk: A systematic review and meta-analysis	12
Efficacy and safety of anti-Tumor Necrosis Factor-α biosimilars in Juvenile Idiopathic Arthritis - a systematic review and meta-analysis	12
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set	12
Age of onset of rheumatoid arthritis and radiographic changes	12
Outcomes in ANCA-associated vasculitis patients with end-stage kidney disease on renal replacement therapy—A meta-analysis	12
Prevalence of frailty and prefrailty in systemic lupus erythematosus: A systematic review and meta-analysis	12
Diffuse idiopathic skeletal hyperostosis in the oncologic population: a cross-sectional analysis of 1053 patients	12
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials	12
Characteristics and long-term outcomes of patients with rheumatoid arthritis and concurrent calcium pyrophosphate deposition disease	12
Developing efficient predictive models for the diagnosis of VEXAS syndrome	12
Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥65 years	12
Cognitive impairment and other neuropsychiatric manifestations in patients with primary vasculitis: a systematic review	12
Efficacy and safety of pharmacological treatments for autoimmune disease-associated interstitial lung disease: A systematic review and network meta-analysis	12
Treatment strategies and outcomes in adult relapsing or refractory cutaneous IgA Vasculitis: A multicenter retrospective cohort study	12
Development and validation analysis of a corrected axial spondyloarthritis metrology index (CASMI)	11
Increased incidence of sudden cardiac death in systemic sclerosis: data from a nationwide cohort study	11
Definitions of rheumatoid arthritis flare and how they relate to patients’ perspectives: A scoping review of qualitative and quantitative evidence	11
Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study	11
Reassessing the prevalence of monophasic, polyphasic and persistent disease courses in still’s disease	11
Emergency department presentations and hospital admissions for patients with biopsy-positive giant cell arteritis in South Australia	11
Telemedicine in rheumatology care: A systematic review	11
Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based study	11
Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological study	11
Pulmonary manifestations of granulomatosis with polyangiitis and microscopic polyangiitis	11
COVID-19 vaccination and systemic autoimmune rheumatic diseases: No evidence of disproportionately increased reporting in VAERS	11
Giant cell arteritis – New treatment targets at the horizon	11
[18F]Sodium Fluoride PET has the potential to identify active formation of calcinosis cutis in limited cutaneous systemic sclerosis	10
Rheumatologist and patient perspectives on axial spondyloarthritis management and treatment satisfaction in Europe	10
SAPHO syndrome: Patient stratification and the new horizon of precision medicine	10
Effectiveness and safety of anti-CD20 monoclonal antibodies versus csDMARDs in anti-Jo-1 antisynthetase syndrome: A retrospective cohort study	10
Assessment of triple antiphospholipid antibody-positive patients based on clinical and laboratory domains of 2023 ACR/EULAR antiphospholipid syndrome classification criteria	10
Prevalence and risk factors of antinuclear antibodies among pregnant women: A cross-sectional study in Qingdao, China	10
Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort	10
Sodium-glucose cotransporter 1 inhibition and gout: Mendelian randomisation study	10
Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study	10
Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activity	10
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group	10
Measurement properties of the decisional conflict scale in people living with chronic non-cancer pain: a secondary analysis of the DECIDE-PAIN pan-Canadian survey	10
Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group	9
Evolution of bone lesions in adults with chronic nonbacterial osteitis (CNO): A long-term follow-up study	9
Sleep disorders in rheumatoid arthritis: Incidence, risk factors and association with dementia	9
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study	9
Patients’ perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group	9
Identifying domains for CNO and SAPHO: A scoping review to create domains from existing outcomes by the OMERACT CNO and SAPHO working group	9
Comparing Raynaud’s phenomenon attack measurement tools: paper or smartphone application?	9
Immune checkpoint inhibitors and rheumatoid arthritis: All roads lead to PD-1?	9
Effect modification by contextual factors of urate-lowering therapy on serum urate in people with gout: A systematic review with meta-regression analysis	9
Macrophages–Autoimmunity–Treatment option	9
The immune pathology of bursitis in rheumatic inflammatory diseases, degenerative conditions and mechanical stress: A systematic review	9
Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials	9
Reply to: Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes	9
Risk of ILD and safety outcomes across DMARD classes in rheumatoid arthritis and RA-ILD	9
Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies	9
Corrigendum to The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time [Seminars in Arthritis and Rheumatism Volume 55, 152010]	9
Polygenic risk scores	9
Joint and muscle inflammatory disease: A scoping review of the published evidence	9
Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus	9
Diffuse idiopathic skeletal hyperostosis (DISH) and trabecular bone score (TBS) in postmenopausal women: The Camargo cohort	9
Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States	9
Taper versus discontinuation of tocilizumab in patients with giant cell arteritis: Real-world experience from a tertiary center	9
Effects of cumulative lifetime estrogen exposure on the clinical characteristics and courses in postmenopausal women with rheumatoid arthritis	9
Role of intravenous immunoglobulins in systemic sclerosis (SSc): A systematic literature review	9
Reply to letter to the editor	8
Moving urate-lowering therapy in gout beyond guideline recommendations	8
Menopausal hormone therapy and risk of seropositive rheumatoid arthritis: A nationwide cohort study in Korea	8
Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies	8
An updated systematic review and meta-analysis of randomised controlled trials on the effects of urate-lowering therapy initiation during a gout flare	8
Risk of major adverse cardiovascular events following targeted therapy in patients with rheumatoid arthritis: a real-world analysis stratified by cardiovascular risk	8
Does smoking protect against developing osteoarthritis? Evidence from a genetically informed perspective	8
Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature	8
Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study	8
Ultra-high frequency ultrasound for digital arteries: improving the characterization of vasculopathy in systemic sclerosis	8
Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study	8
Serological Stratification by Anti-Ro52 and Anti-Ro60 Profiles Reveals Distinct Systemic Phenotypes in Primary Sjögren's Disease	8
Development of a prediction model for poor prognosis in childhood-onset Takayasu's arteritis	8
Factors associated with thrombosis in Behçet Syndrome: A systematic review and meta-analysis	8
Identification of outcome domains in primary Sjögren's disease: A scoping review by the OMERACT Sjögren disease working group	8
Healthy dietary pattern and risk of rheumatoid arthritis: A systematic review and meta-analysis	8
Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set	8
Come rain or shine: Is weather a risk factor for musculoskeletal pain? A systematic review with meta-analysis of case-crossover studies	8
Adipocytokines and achievement of low disease activity in rheumatoid arthritis	8
Validation studies of rheumatoid arthritis patient-reported outcome measures in populations at risk for inequity: A systematic review and analysis using the OMERACT summary of measurement properties e	8
Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)	8
Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study	8
Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extens	8
Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis	8
Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis	8
2025 Consensus-based recommendations for the referral, diagnosis, monitoring, and management of axial spondyloarthritis in the Arabian Gulf countries	8
Reply: Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A systematic review and meta-analysis	8
Traditional laboratory parameters and IFNγ-related biomarkers in the diagnosis and management of MAS	8
Comment on "Risk and temporal trends of heart failure subtypes in rheumatoid arthritis"	8
Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023	8
Why most (but perhaps not all) DMARDs work equally well	8
Brain white matter microstructural alterations in Behcet's syndrome correlate with cognitive impairment and disease severity: A diffusion tensor imaging study	8
The use of ASDAS to evaluate disease activity and response to treatment in patients with axial spondyloarthritis starting the first biological drug: Are ASAS recommendations being followed?	8